Paul William THOMPSON

Person

Cambridge, GB

People

Patents Applicationslast 30 patents

Information Patent Application
1-(5-(2-CYANOPYRIDIN-4-YL)OXAZOLE-2-CARBONYL)-4-METHYLHEXAHYDROPYRR...
- Publication number 20230312580
- Publication date Oct 5, 2023
- Mission Therapeutics Limited
- Christopher Andrew LUCKHURST
- C07 - ORGANIC CHEMISTRY
Information Patent Application
N-CYANOPYRROLIDINES WITH ACTIVITY AS USP30 INHIBITORS
- Publication number 20230303547
- Publication date Sep 28, 2023
- Mission Therapeutics Limited
- Christopher Andrew LUCKHURST
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
N-(1-CYANO-PYRROLIDIN-3-YL)-5-(3-(TRIFLUOROMETHYL)PHENYL)OXAZOLE-2-...
- Publication number 20230219939
- Publication date Jul 13, 2023
- Mission Therapeutics Limited
- Christopher Andrew LUCKHURST
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
N-CYANOPYRROLIDINES WITH ACTIVITY AS USP30 INHIBITORS
- Publication number 20230119013
- Publication date Apr 20, 2023
- Mission Therapeutics Limited
- Christopher Andrew LUCKHURST
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED CYANOPYRROLIDINES WITH ACTIVITY AS USP30 INHIBITORS
- Publication number 20220315572
- Publication date Oct 6, 2022
- Mission Therapeutics Limited
- Paul William THOMPSON
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CYANOPYRROLIDINES AS USP30 INHIBITORS AND FIBROSIS TREATMENT
- Publication number 20210002262
- Publication date Jan 7, 2021
- Mission Therapeutics Limited
- Paul William THOMPSON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Paul William THOMPSON

Person

Patents Applicationslast 30 patents

1-(5-(2-CYANOPYRIDIN-4-YL)OXAZOLE-2-CARBONYL)-4-METHYLHEXAHYDROPYRR...

N-CYANOPYRROLIDINES WITH ACTIVITY AS USP30 INHIBITORS

N-(1-CYANO-PYRROLIDIN-3-YL)-5-(3-(TRIFLUOROMETHYL)PHENYL)OXAZOLE-2-...

N-CYANOPYRROLIDINES WITH ACTIVITY AS USP30 INHIBITORS

SUBSTITUTED CYANOPYRROLIDINES WITH ACTIVITY AS USP30 INHIBITORS

CYANOPYRROLIDINES AS USP30 INHIBITORS AND FIBROSIS TREATMENT